Video
Webinar – Mastering Complex Proteins: A Roadmap to Success
Thanks for joining us – if you would like to re-watch the webinar, the video has been made available below to watch again.
Downloadable
White paper: Bacillus subtilis as a microbial host for recombinant protein expression
The performance and economics of any bioprocess are significantly impacted by the choice of host platform. Ingenza’s diverse range of bacterial, yeast and mammalian production platforms is an excellent foundation for biomanufacturing development. In this white paper, Rita Cruz, Section Head of…
Downloadable
White paper: Analytical insights to advance biopharmaceutical development
Ingenza has a comprehensive suite of validated analytical methods and assays that can be readily employed to fully characterise both small molecules and biologics targets throughout all stages of bioprocess development and optimisation. We aim to deliver high quality results…
Blog entry
Elevating quality management with bespoke digital solutions
The biopharmaceutical sector is expanding twice as fast as traditional drug manufacturing, and currently accounts for 20 percent of the pharmaceutical industry.1,2 Biotechnology companies are therefore under increasing pressure to maintain a rapid pace of development, while providing trackable documentation to…
Article
Ingenza expanding codABLE gene design algorithm to aid recombinant protein production in yeast
Scottish CRDMO Ingenza has secured innovation funding to adapt its codABLE machine learning platform to precisely control recombinant protein expression in the industrial yeast Pichia pastoris. This game-changing project will accelerate the development of therapeutics, enzymes and other proteins by harnessing machine learning to…
Blog entry
Redefining recombinant protein production to accelerate biopharmaceutical development
Recombinant protein production is an important technique for generating large quantities of proteins in a variety of pharmaceutical, agricultural and industrial applications. It is widely used in the development and manufacture of drugs – such as insulin, growth factors and…
Article
Ingenza selects Opvia as its QMS provider to elevate biotech innovations
Edinburgh, Scotland – Ingenza, a dynamic CDMO and leader in engineering biology, is pleased to announce its strategic partnership with Opvia, a Quality Management Systems (QMS) provider. This partnership is driven by Ingenza’s commitment to enhance and centralise its quality…
Article
Introducing a novel fluorescent marker to assess antimicrobial peptide production in Pichia pastoris
Ingenza is proud to announce that our molecular biology team recently co-authored a groundbreaking research paper published in Applied Microbiology International. The study addressed current challenges in producing recombinant proteins in the methylotrophic yeast Pichia pastoris. P. pastoris is a…
Article
Celebrating Alison Arnold’s 20 years at Ingenza
The entire team at Ingenza is sending heartfelt congratulations to our very own Dr Alison Arnold as she celebrates an amazing 20 years of working with us! Alison Arnold, PhD, joined Ingenza in 2003 as Senior Scientist for our fermentation…
Article
Ingenza’s revolutionary pH strips improve nasogastric feeding tube placement
Ingenza’s novel ester-impregnated pH strips significantly improve the accuracy of locating nasogastric (NG) feeding tubes in a study carried out in 10 NHS hospitals, as published in Diagnostic and Prognostic Research. The peer-reviewed paper found the innovative test to be…